<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045212"><TermName>pyrazine diazohydroxide</TermName><TermPronunciation>(PEER-uh-zeen dy-A-zoh-hy-DROK-side)</TermPronunciation><TermDefinition><DefinitionText>A substance that is being studied in the treatment of cancer.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000730795" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;pyrazine diazohydroxide&quot;" language="en" id="_3"/><MediaLink ref="CDR0000730794" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;diazohidróxido de pirazina&quot;" language="es" id="_4"/><SpanishTermName>diazohidróxido de pirazina</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento del cáncer</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2005-02-15</DateLastModified></GlossaryTerm>
